ATE454469T1 - Für den nachweis von nukleinsäuren kompetente biologische rohderivate - Google Patents

Für den nachweis von nukleinsäuren kompetente biologische rohderivate

Info

Publication number
ATE454469T1
ATE454469T1 AT03710760T AT03710760T ATE454469T1 AT E454469 T1 ATE454469 T1 AT E454469T1 AT 03710760 T AT03710760 T AT 03710760T AT 03710760 T AT03710760 T AT 03710760T AT E454469 T1 ATE454469 T1 AT E454469T1
Authority
AT
Austria
Prior art keywords
detection
competent
derivatives
nucleic acids
biological raw
Prior art date
Application number
AT03710760T
Other languages
English (en)
Inventor
Brittan Pasloske
Hoang Quoc
Original Assignee
Ambion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27663090&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE454469(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ambion Inc filed Critical Ambion Inc
Application granted granted Critical
Publication of ATE454469T1 publication Critical patent/ATE454469T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03710760T 2002-01-28 2003-01-28 Für den nachweis von nukleinsäuren kompetente biologische rohderivate ATE454469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35240202P 2002-01-28 2002-01-28
PCT/US2003/002439 WO2003064605A2 (en) 2002-01-28 2003-01-28 Crude biological derivatives competent for nucleic acid detection

Publications (1)

Publication Number Publication Date
ATE454469T1 true ATE454469T1 (de) 2010-01-15

Family

ID=27663090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03710760T ATE454469T1 (de) 2002-01-28 2003-01-28 Für den nachweis von nukleinsäuren kompetente biologische rohderivate

Country Status (6)

Country Link
US (6) US20030170617A1 (de)
EP (4) EP2290098A1 (de)
AT (1) ATE454469T1 (de)
DE (1) DE60330842D1 (de)
HK (1) HK1210627A1 (de)
WO (1) WO2003064605A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511680A (en) 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
EP2290098A1 (de) 2002-01-28 2011-03-02 Ambion, Inc. Herstellung biologische Rohderivaten unter Einzetsung Proteasen, geeignet für cDNA Synthese
CA2518569C (en) * 2003-03-10 2011-11-15 Expression Pathology, Inc. Liquid tissue preparation from histopathologically processed biological samples, tissues and cells
CN1580283A (zh) * 2003-08-13 2005-02-16 清华大学 一种检测核酸分子的方法
US20050208501A1 (en) 2004-03-16 2005-09-22 Ambion, Inc. Process and reagents for extraction of RNA from fractionated blood leukocytes
US20050239055A1 (en) * 2004-04-22 2005-10-27 Mariani Brian D Enterovirus primers and probes
US7575864B2 (en) * 2004-05-27 2009-08-18 E.I. Du Pont De Nemours And Company Method for the direct detection of diagnostic RNA
US20050277121A1 (en) * 2004-06-11 2005-12-15 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
SG178651A1 (en) * 2004-06-17 2012-03-29 Zygem Corp Ltd Purification methods and uses thereof
US20060188892A1 (en) * 2005-02-18 2006-08-24 Ambion, Inc. Enzymatic digestion of tissue
EP2049688B1 (de) * 2006-08-01 2018-01-24 Applied Biosystems, LLC Nachweis von analyten und nukleinsäuren
EP2147119B1 (de) * 2007-05-03 2011-05-25 Roche Diagnostics GmbH mRNA-QUANTIFIZIERUNG EINER EINZELZELLE MITTELS ECHTZEIT-RT-PCR
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
WO2010012464A1 (en) 2008-08-01 2010-02-04 Roche Diagnostics Gmbh Improved lysis and reverse transcription for mrna quantification
EP2955233A1 (de) 2008-12-19 2015-12-16 Life Technologies Corporation Proteinase K Inhibitore, Verfahren und Zusammensetzungen davon
US9422542B2 (en) 2010-02-26 2016-08-23 Qiagen Gmbh Process for parallel isolation and/or purification of RNA and DNA
EP2559764A1 (de) 2011-08-17 2013-02-20 Qiagen GmbH Zusammensetzung und Verfahren für reverse Transkriptase-Polymerase-Kettenreaktion (RT-PCR )mit einem anionischen Polymer
CN113774163A (zh) * 2014-04-28 2021-12-10 奎斯特诊断投资股份有限公司 肠道病毒和双埃柯病毒的分子检测
EP3368668B1 (de) 2015-10-28 2023-11-29 Silicon Valley Scientific, Inc. Verfahren und vorrichtung zur codierung von zellularen räumlichen positionsinformationen
US20170166956A1 (en) * 2015-12-11 2017-06-15 Shoreline Biome, Llc Methods for DNA Preparation for Multiplex High Throughput Targeted Sequencing
JP2019517780A (ja) 2016-04-14 2019-06-27 ティー２ バイオシステムズ，インコーポレーテッド 複合試料における増幅のための方法及びシステム
US10894990B2 (en) 2016-05-17 2021-01-19 Shoreline Biome, Llc High throughput method for identification and sequencing of unknown microbial and eukaryotic genomes from complex mixtures
US11231347B2 (en) 2016-11-29 2022-01-25 S2 Genomics, Inc. Method and apparatus for processing tissue samples
GB201803654D0 (en) 2018-03-07 2018-04-25 Arcticzymes As Thermolabile proteinases
CA3102089A1 (en) 2018-06-01 2019-12-05 S2 Genomics, Inc. Method and apparatus for processing tissue samples
CN108588224A (zh) * 2018-06-14 2018-09-28 大连医科大学附属第医院 一种用于嗜铬细胞瘤/副神经节瘤早期诊断和术前评估的生物标志物及其应用
WO2021221109A1 (ja) * 2020-04-30 2021-11-04 タカラバイオ株式会社 Ｒｎａウイルスの検出方法
FR3116065A1 (fr) * 2020-11-12 2022-05-13 Innovative Diagnostics Genetics Détection d’acides nucléiques dans un échantillon biologique
CN113151398A (zh) * 2021-05-07 2021-07-23 广州复能基因有限公司 外泌体中核酸分子的检测方法

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124317B1 (de) 1983-04-27 1990-04-11 Ici Americas Inc. Prolin-Derivate
GB8600263D0 (en) 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5194588A (en) 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
US4900677A (en) * 1986-09-26 1990-02-13 E. I. Du Pont De Nemours And Company Process for rapid isolation of high molecular weight DNA
CA1317860C (en) 1987-04-01 1993-05-18 Daniel Louis Kacian Techniques for preparing specimens for bacterial assays
US5008245A (en) 1988-10-27 1991-04-16 University Of Kentucky Research Foundation Novel peptidyl carbamate inhibitors of the enzyme elastase
NO177716C (no) 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
CA2021660A1 (en) 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US4997932A (en) * 1989-11-13 1991-03-05 Boehringer Mannheim Corporation Method and kit for purifying nucleic acids
US5284940A (en) * 1990-11-14 1994-02-08 Hri Research, Inc. Preparation for nucleic acid samples
US5284829A (en) 1991-11-26 1994-02-08 The Regents Of The University Of California Synthetic tetrapeptides for the prevention of schistosome parasite infection
MX9300492A (es) 1992-01-29 1994-07-29 Hitachi Chemical Co Ltd Soporte inmovilizado de nucleotido y metodo para su produccion.
AU681082B2 (en) 1992-05-06 1997-08-21 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
US5386024A (en) * 1993-02-10 1995-01-31 Gen-Probe Incorporated Method to prepare nucleic acids from a biological sample using low pH and acid protease
EP0698082A4 (de) 1993-05-06 1997-12-17 Abbott Lab Ein puffer zur direkten lyse und die feststellung der hiv-1 plasma virämie
AU692237B2 (en) 1994-02-03 1998-06-04 Picower Institute For Medical Research, The Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
KR100238833B1 (ko) * 1994-03-10 2000-03-02 다니엘 엘. 캐시앙 이온성 세제에 의한 효소 개재 반응의 억제를 방지하는 방법
US5712095A (en) * 1994-06-16 1998-01-27 Becton Dickinson And Company Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors
WO1996000228A1 (en) * 1994-06-23 1996-01-04 Dade International Inc. Method for the rapid isolation of nucleic acid
US5693467A (en) 1995-05-19 1997-12-02 The American Type Culture Collection Mycoplasma polymerase chain reaction testing system using a set of mixed and single sequence primers
WO1997035589A1 (en) * 1996-03-26 1997-10-02 Kopreski Michael S Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
US5939262A (en) 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US5677124A (en) 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US6218105B1 (en) * 1996-07-19 2001-04-17 Kathleen S. Hall High throughput papilloma virus in vitro infectivity assay
US5871628A (en) 1996-08-22 1999-02-16 The University Of Texas System Automatic sequencer/genotyper having extended spectral response
ATE438719T1 (de) * 1997-03-07 2009-08-15 Siemens Healthcare Diagnostics Spezifischer marker für prostatakrebs
EP1023460A4 (de) * 1997-06-25 2003-09-10 Promega Corp Verfahren zur isolierung von rna
US6111096A (en) * 1997-10-31 2000-08-29 Bbi Bioseq, Inc. Nucleic acid isolation and purification
EP1032595B1 (de) 1997-11-18 2011-05-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Nukleinsäure involviert im responder phenotyp und deren verwendung
WO1999037668A1 (de) 1998-01-26 1999-07-29 Basf Aktiengesellschaft Thrombininhibitoren
US6583301B1 (en) 1998-04-08 2003-06-24 Celltech R & D Limited Lipids
US6204375B1 (en) 1998-07-31 2001-03-20 Ambion, Inc. Methods and reagents for preserving RNA in cell and tissue samples
AU755499B2 (en) 1998-09-18 2002-12-12 Micromet Ag DNA amplification of a single cell
US6777210B1 (en) * 1998-09-24 2004-08-17 Ambion, Inc. Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1
US6265165B1 (en) * 1998-11-12 2001-07-24 The Regents Of The University Of California Methods for EST-specific full length cDNA cloning
WO2000034504A2 (en) 1998-12-10 2000-06-15 Genetic Vectors, Inc. Method of protein removal
DE19916534A1 (de) * 1999-04-13 2000-10-19 Gsf Forschungszentrum Umwelt RNA-Isolierungs-Kit
CA2378944A1 (en) 1999-07-23 2001-02-01 Genentech, Inc. Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration
US7264932B2 (en) 1999-09-24 2007-09-04 Applera Corporation Nuclease inhibitor cocktail
EP1220944B1 (de) * 1999-09-24 2010-09-15 Ambion, Inc. Cocktail von nukleaseinhibitoren
WO2001042507A1 (en) 1999-12-09 2001-06-14 Advanced Research & Technology Institute Fluorescent in situ rt-pcr
US6316608B1 (en) 2000-03-20 2001-11-13 Incyte Genomics, Inc. Combined polynucleotide sequence as discrete assay endpoints
US7001724B1 (en) 2000-11-28 2006-02-21 Applera Corporation Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
JP2004523229A (ja) 2001-01-16 2004-08-05 インヴィトロジェン コーポレーション Ｒｎａ単離のための試薬
US20020172972A1 (en) 2001-05-15 2002-11-21 President And Fellows Of Harvard College Use of a selectively inactivatable enzyme to digest contaminating nucleic acid
US7229810B2 (en) 2001-06-28 2007-06-12 Mountain View Pharmaceuticals, Inc. Polymer conjugates of proteinases
EP2290098A1 (de) 2002-01-28 2011-03-02 Ambion, Inc. Herstellung biologische Rohderivaten unter Einzetsung Proteasen, geeignet für cDNA Synthese
US20040038213A1 (en) 2002-08-06 2004-02-26 Kwon Jai W. Genotyping by in situ PCR amplification of a polynucleotide in a tissue biopsy
US7214484B2 (en) 2002-12-17 2007-05-08 Sigma-Aldrich Co. Compositions and methods for nucleic acid extraction from biological samples
WO2004076640A2 (en) 2003-02-25 2004-09-10 Ambion, Inc. Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same
US7067298B2 (en) 2003-03-31 2006-06-27 Ambion, Inc. Compositions and methods of using a synthetic Dnase I
CN1798838B (zh) 2003-04-04 2012-01-04 洛桑大学 一种蛋白酶的抑制剂蛋白及其用途
US20050069953A1 (en) 2003-09-30 2005-03-31 Ye Fang Assay solution compositions and methods for GPCR arrays
US20050277121A1 (en) 2004-06-11 2005-12-15 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
WO2006047482A2 (en) 2004-10-22 2006-05-04 Redpath Integrated Pathology, Inc. Method for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts using cyst aspirate
US20060188892A1 (en) 2005-02-18 2006-08-24 Ambion, Inc. Enzymatic digestion of tissue
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
EP2955233A1 (de) 2008-12-19 2015-12-16 Life Technologies Corporation Proteinase K Inhibitore, Verfahren und Zusammensetzungen davon

Also Published As

Publication number Publication date
US9611497B2 (en) 2017-04-04
EP2902501A1 (de) 2015-08-05
US20130143275A1 (en) 2013-06-06
DE60330842D1 (de) 2010-02-25
US20030170617A1 (en) 2003-09-11
EP2902501B1 (de) 2020-04-15
US10233444B2 (en) 2019-03-19
US20170218359A1 (en) 2017-08-03
US10590411B2 (en) 2020-03-17
EP1476573B1 (de) 2010-01-06
EP2163652B2 (de) 2023-05-31
US20180340175A1 (en) 2018-11-29
HK1210627A1 (en) 2016-04-29
US20120322112A1 (en) 2012-12-20
WO2003064605A3 (en) 2004-02-19
US20190270988A1 (en) 2019-09-05
WO2003064605A2 (en) 2003-08-07
EP2163652A1 (de) 2010-03-17
EP2290098A1 (de) 2011-03-02
EP1476573A2 (de) 2004-11-17
EP1476573A4 (de) 2005-12-14
EP2163652B1 (de) 2014-12-24
US10011831B2 (en) 2018-07-03

Similar Documents

Publication Publication Date Title
ATE454469T1 (de) Für den nachweis von nukleinsäuren kompetente biologische rohderivate
CY1119878T1 (el) Μια μεθοδος για απομονωση πυρηνικων οξεων και ενα kit εξ' αυτης
DK1157264T3 (da) Biokemiske oprensningsindretninger med immobiliserede opfangningsprober og anvendelser deraf
ATE540114T1 (de) Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle
ATE515488T1 (de) Click-chemie zur herstellung von reportermolekülen
DE60310944D1 (de) Weitere neue formen von interferierende rns moleküle
NO20072722L (no) Preparater og fremgangsmate for a rense nukleinsyrer fra stabiliseringsreagenser
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
EE200100340A (et) Meetod signaali võimendamiseks, meetod kogu sihtnukleiinhappemolekuli või selle osa sekveneerimiseks, reaktiivikomplekt ja meetod sihtnukleiinhappemolekuli kaardistamiseks
WO2010059731A3 (en) Polynucleotide mapping and sequencing
ATE534748T1 (de) Direkter snp-nachweis mit nichtamplifizierter dna
ATE491809T1 (de) Amplifikation von dna-fragmenten
DE60039037D1 (de) Methode zur direkten sequenzierung von nukleinsäuren
DE60038244D1 (de) Methode zur dns sequenzierung
DE602006019475D1 (de) Verfahren zur mikrorna-identifikation und ihrer anwendungen bei der forschung und menschlichen gesundheit
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE602005009693D1 (de) 2"-nitrobenzyl-modifizierte ribonukleotide
SE0301951D0 (sv) New method
EA200200094A1 (ru) Нуклеиновые кислоты-лиганды тенасцина-с
ATE393237T1 (de) Mittel und verfahren zur in-vitro-bestimmung von camp
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
GB2409457B (en) Method to generate or determine nucleic acid tags corresponding to the terminal ends of DNA molecules using sequence analysis of gene expression(terminal SAGE
GB0509611D0 (en) Method and device for imaging a sample
DE602004017666D1 (de) Methode zur getrennten Isolierung von DNS und RNS und Kit zur Isolierung von Nukleinsäuren
ATE242261T1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties